Artificial intelligence continues to transform biotechnology, with new developments in automated gene editing and clinical trial recruitment. The CRISPR-GPT system integrates large language models to automate design and analysis of gene-editing experiments, democratizing access for researchers. Separately, ChatGPT and similar AI tools have demonstrated the capacity to streamline patient screening for clinical trials, potentially accelerating enrollment processes. Additionally, AI models are enhancing cancer diagnostics and prognostic predictions, including lung adenocarcinoma grading and aortic stenosis progression.